医薬品ガラス包装市場の2030年までの予測：セグメント別、地域別の世界分析

Stratistics MRCによると、世界の医薬品ガラス包装市場は2023年に201億米ドルを占め、予測期間中にCAGR 11.4％で成長し、2030年には429億米ドルに達すると予想されています。

医薬品ガラス包装は、医薬品の保存と保護を目的としたガラス容器の製造と流通を包括しています。これらのガラス包装は、無菌で不浸透性の環境を提供し、医薬品の完全性、効力、安定性を保護することで、保存期間を通じて医薬品の有効性を維持します。医薬品ガラス包装には、バイアル、ボトル、アンプル、シリンジなど様々な形状があり、多様な薬剤の種類や送達方法に対応しています。

米国メディケア＆メディケイドサービスセンターによると、米国の国民医療費は年率5.4%で成長し、2028年には6兆2,000億米ドルに達すると予想されています。

ガラスの商品価値はリサイクル可能性で上昇

ガラスはリサイクル可能性が高く、その持続可能な性質は、環境問題への関心の高まりと一致しています。品質を損なうことなく無限にリサイクルできるガラスは、環境意識の高い消費者や産業界にとって好ましい選択肢となっています。持続可能性が重視されるにつれ、ガラスのようなリサイクル可能な素材で包装された製品の需要が高まっています。この動向は市場の成長を促進するだけでなく、環境に配慮した包装ソリューションを採用することの重要性を強調し、様々な分野におけるガラス包装の魅力と競争力を高めています。

限られた技術革新

プラスチックのような産業が、新しい製造技術やスマートなパッケージング・ソリューションによって急速に発展してきたのに対し、ガラス包装の進歩は遅かっています。この技術革新の不足が、ガラスが現代の市場の要求に効果的に応える可能性を制限しています。追跡、改ざん防止、消費者との相互作用などのスマート包装機能は、技術的に適応性の高い素材に比べ、従来のガラス包装では実現性が低いです。さらに、製薬業界では薬物放出制御システムのような特殊な包装を必要としているが、ガラスは汎用性に乏しいため、その妨げになる可能性があります。

新興国における医薬品産業の成長

新興国ではヘルスケアのニーズが高まり、中間層の人口が増加しているため、医薬品とそれに対応する包装ソリューションに対する需要が高まっています。医薬品の完全性、安定性、無菌性を保証するガラス包装の能力は、医薬品の厳しい品質要件に合致しています。さらに、持続可能性と高級包装への注目は、ガラスの魅力を高めています。新興国で急成長している医薬品市場を活用することで、ガラス包装メーカーは大きな顧客基盤を獲得し、医薬品の安全かつ効果的な供給に貢献することができます。

代替素材の重要性の高まり

プラスチック、紙、その他の素材の革新に伴い、産業界は軽量化、輸送コストの削減、生分解性の向上といった選択肢を模索しています。持続可能性が注目されるにつれ、ガラスの製造と輸送が環境に与える影響が認識され、ガラスの地位が低下する可能性があります。製造業者は、環境意識の高い消費者の嗜好に沿った素材を選ぶよう、ますます迫られています。このようなコスト効率や環境への配慮といった要因による代替素材へのシフトは、包装におけるガラスの伝統的優位性に課題を投げかけ、その市場シェアと成長軌道に影響を与える可能性があります。

COVID-19の影響：

COVID-19のパンデミックは、いくつかの産業でサプライチェーンの混乱と原材料の不足を経験したが、医薬品セクターにはほとんど影響を与えなかっています。製薬企業は地域社会にとって不可欠であるため、操業停止規制の対象外となっています。また、包装事業の一部も操業停止の制限を免除され、ヘルスケアの生産とサポートに機能していました。同市場の事業者は、COVID-19に関連する医薬品用包装の需要拡大に対応するため、工程の自動化や、ウイルスの拡散を防ぐために可能な限り少ない人的資源を割り当てるなどしています。

予測期間中、ボトル・セグメントが最大となる見込み

ボトル・セグメントは、様々な液体医薬品や固形剤形の一次容器として有利な成長が見込まれています。その不活性で不浸透性の特性は、医薬品の安定性と完全性を保証し、製品の有効性を維持するために不可欠です。ボトルには、正確な投薬用の小さなスポイトボトルから大量投薬用の大きな容器まで、さまざまなサイズがあります。ボトルには、開封防止シールや小児用キャップなどの機能があり、患者の安全性を高めています。医薬品のニーズが進化し、患者の利便性が重視される中、ボトルは医薬品業界の厳しい規制要件を満たす安全で使い勝手の良いパッケージング・ソリューションを提供する上で極めて重要な役割を果たしています。

予測期間中、ジェネリック部門が最も高いCAGRが見込まれる

ジェネリック医薬品分野は、予測期間中に最も速いCAGR成長が見込まれます。ジェネリック医薬品は、ブランド医薬品と生物学的に同等な非ブランド医薬品です。ジェネリック医薬品は多くの場合ガラス包装であり、医薬品の安全性と有効性を維持しながら、費用対効果の高い代替品を提供しています。ガラス容器は、湿気、酸素、光に対するバリアを提供することでジェネリック医薬品の安定性を確保し、効力を保持します。このようなパッケージング・ソリューションは、必要不可欠な医薬品の手頃な価格と入手しやすさに貢献しています。ヘルスケアコスト抑制の取り組みによりジェネリック医薬品の需要が増加し続ける中、医薬品ガラス包装は、より多くの人々に高品質で価値主導のヘルスケアソリューションを提供する上で極めて重要な役割を果たしています。

最もシェアの高い地域

予測期間中、北米の医薬品ガラス包装市場が引き続き市場シェアの大半を占めると予想されます。同地域では患者の安全性、医薬品の完全性、製品の差別化が重視されているため、高品質のガラス容器に対する需要が高まっています。先進的な製造能力と技術革新により、北米ではバイアル、ボトル、シリンジを含む幅広い医薬品ガラス包装ソリューションが生産されています。大手製薬会社が存在し、ヘルスケアのインフラが整備されていることが、高級包装オプションの採用を後押ししています。さらに、この地域の持続可能な包装への注力は世界の動向と一致しており、北米が医薬品ガラス包装の展望を形成する上で重要な役割を担っています。

CAGRが最も高い地域：

アジア太平洋地域は、製薬業界の急成長とヘルスケアセクターの拡大により、予測期間中のCAGRが最も高くなると予測されています。同地域では医薬品の需要が増加しており、製品の安全性と保存性が重視されるようになっているため、高品質なガラスパッケージング・ソリューションへのニーズが高まっています。有利な規制状況と可処分所得の増加は、医薬品ガラス包装市場をさらに活性化させます。アジア太平洋地域の製造能力は、主要企業の存在や革新的な技術と相まって、医薬品の完全性と有効性の維持に不可欠な幅広いガラス容器、バイアル、アンプルの供給において重要な役割を果たしています。

無料のカスタマイズサービス

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の医薬品ガラス包装市場：製品別

• バイアル
  • 小型バイアル
  • 大型バイアル
• ボトル
  • 小型ボトル
  • 大型ボトル
• カートリッジとシリンジ
• アンプル

第6章 世界の医薬品ガラス包装市場：医薬品タイプ別

• ジェネリック
• ブランド
• バイオロジクス

第7章 世界の医薬品ガラス包装市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第8章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイル

• Schott AG
• Nipro Corporation
• Owens-Illinois, Inc.
• Arab Pharmaceutical Glass Co.
• Sisecam Group
• Stoelzle Oberglas GmbH
• West Pharmaceutical Services, Inc.
• Beatson Clark
• Bormioli Pharma S.p.A.
• Corning Incorporated
• Shandong Medicinal Glass Co., Ltd.
• Ardagh Group S.A
• Piramal Enterprises Ltd.
• Gerresheimer AG

List of Tables

• Table 1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 4 Global Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 5 Global Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 6 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 7 Global Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 8 Global Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 9 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 10 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 11 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 12 Global Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 13 Global Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 14 Global Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
• Table 15 North America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
• Table 16 North America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 17 North America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 18 North America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 19 North America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 20 North America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 21 North America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 22 North America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 23 North America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 24 North America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 25 North America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 26 North America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 27 North America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 28 North America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
• Table 29 Europe Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
• Table 30 Europe Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 31 Europe Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 32 Europe Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 33 Europe Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 34 Europe Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 35 Europe Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 36 Europe Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 37 Europe Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 38 Europe Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 39 Europe Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 40 Europe Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 41 Europe Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 42 Europe Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
• Table 43 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
• Table 44 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 45 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 46 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 47 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 48 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 49 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 50 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 51 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 52 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 53 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 54 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 55 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 56 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
• Table 57 South America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
• Table 58 South America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 59 South America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 60 South America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 61 South America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 62 South America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 63 South America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 64 South America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 65 South America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 66 South America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 67 South America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 68 South America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 69 South America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 70 South America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
• Table 71 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
• Table 72 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
• Table 73 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
• Table 74 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
• Table 75 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
• Table 76 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
• Table 77 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
• Table 78 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
• Table 79 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
• Table 80 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
• Table 81 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
• Table 82 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
• Table 83 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
• Table 84 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)

According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $20.1 billion in 2023 and is expected to reach $42.9 billion by 2030 growing at a CAGR of 11.4% during the forecast period. The pharmaceutical glass packaging encompasses the production and distribution of glass containers designed to store and protects pharmaceutical products. These glass packaging solutions provide a sterile and impermeable environment that safeguards the integrity, potency, and stability of medications, ensuring they remain effective throughout their shelf life. Pharmaceutical glass packaging comes in various forms, such as vials, bottles, ampoules, and syringes, catering to diverse medication types and delivery methods.

According to the U.S. Centers for Medicare & Medicaid Services, the national health spending of the country is expected to grow at an annual rate of 5.4% and reach USD 6.2 trillion by 2028.

Market Dynamics:

Driver:

Commodity value of glass increased with recyclability

Glass is highly recyclable, and its sustainable nature aligns with increasing environmental concerns. The ability to be infinitely recycled without compromising quality makes glass a preferred choice for eco-conscious consumers and industries. As sustainability becomes a central focus, the demand for products packaged in recyclable materials, such as glass, has risen. This trend not only enhances the market's growth but also underscores the importance of adopting environmentally responsible packaging solutions, bolstering the attractiveness and competitiveness of glass packaging in various sectors.

Restraint:

Limited technological innovations

While industries like plastics have rapidly evolved with new manufacturing techniques and smart packaging solutions, glass packaging has experienced slower progress. This deficiency in innovation restricts the potential for glass to meet modern market demands effectively. Smart packaging features such as tracking, tamper-evidence, and interaction with consumers are less feasible in traditional glass packaging compared to more technologically adaptable materials. Moreover, the pharmaceutical industry's need for specialized packaging, such as controlled drug release systems, can be impeded by glass's relative lack of versatility.

Opportunity:

Growth of pharmaceutical industry in emerging economies

As these regions experience increasing healthcare needs and expanding middle-class populations, there is a higher demand for medicines and corresponding packaging solutions. Glass packaging's ability to ensure drug integrity, stability, and sterility aligns with the stringent quality requirements of pharmaceutical products. Moreover, the focus on sustainability and premium packaging enhances the appeal of glass. Capitalizing on the burgeoning pharmaceutical markets in emerging economies allows glass packaging manufacturers to tap into a significant customer base and contribute to the safe and effective delivery of medications.

Threat:

Increased relevance of alternate material

With innovations in plastics, paper, and other materials, industries are exploring options that offer lighter weight, reduced transportation costs, and improved biodegradability. As sustainability gains prominence, the perceived environmental impact of glass production and transportation might weaken its position. Manufacturers are increasingly pressured to choose materials that align with eco-conscious consumer preferences. This shift towards alternative materials, driven by factors such as cost efficiency and environmental considerations, challenges the traditional dominance of glass in packaging, potentially impacting its market share and growth trajectory.

COVID-19 Impact:

The COVID-19 pandemic experienced supply chain disruptions and a lack of raw materials in several industries, but it had little impact on the pharmaceutical sector. Pharmaceutical businesses were exempt from shutdown restrictions because they are vital to the community. A few of packaging businesses were also exempted from the lockdown limitations and were functioning to produce and support healthcare items. Businesses in the market are responding to the growing demand for packaging for pharmaceutical items connected to COVID-19 by automating their processes and allocating the fewest possible human resources in order to prevent the spread of the virus.

The bottles segment is expected to be the largest during the forecast period

The bottles segment is expected to have a lucrative growth serving as primary containers for various liquid medications and solid dosage forms. Their inert and impermeable properties ensure drug stability and integrity, vital for preserving product efficacy. Bottles come in a range of sizes, from small dropper bottles for precise dosing to larger containers for bulk medications. They offer features such as tamper-evident seals and child-resistant closures, enhancing patient safety. With evolving pharmaceutical needs and a growing focus on patient convenience, bottles play a pivotal role in providing secure and user-friendly packaging solutions that meet stringent regulatory requirements in the pharmaceutical industry.

The generic segment is expected to have the highest CAGR during the forecast period

The generic segment is anticipated to witness the fastest CAGR growth during the forecast period. Generic is non-branded medications that are bioequivalent to their branded counterparts. Generic pharmaceuticals often come in glass packaging, offering cost-effective alternatives while maintaining drug safety and efficacy. Glass containers ensure the stability of generic medicines by providing a barrier against moisture, oxygen, and light, preserving their potency. These packaging solutions contribute to the affordability and accessibility of essential medications. As the demand for generic drugs continues to rise due to healthcare cost containment efforts, pharmaceutical glass packaging plays a pivotal role in delivering high-quality, value-driven healthcare solutions to a broader population.

Region with largest share:

During the forecast period, it is expected that the North America Pharmaceutical Glass Packaging market will continue to hold a majority of the market share. The region's emphasis on patient safety, drug integrity, and product differentiation fuels the demand for high-quality glass containers. With advanced manufacturing capabilities and innovation, North America produces a wide array of pharmaceutical glass packaging solutions, including vials, bottles, and syringes. The presence of major pharmaceutical companies and a well-established healthcare infrastructure drives the adoption of premium packaging options. Additionally, the region's focus on sustainable packaging aligns with global trends, solidifying North America's significant role in shaping the pharmaceutical glass packaging landscape.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period due to its burgeoning pharmaceutical industry and expanding healthcare sector. The region's increasing demand for medicines, along with a growing focus on product safety and preservation, drives the need for high-quality glass packaging solutions. Favorable regulatory landscapes and rising disposable incomes further boost the pharmaceutical glass packaging market. Local manufacturing capabilities, coupled with the presence of key players and innovative technologies, contribute to Asia Pacific's significant role in supplying a wide range of glass containers, vials, and ampoules, essential for maintaining the integrity and efficacy of pharmaceutical products.

Key players in the market:

Some of the key players in Pharmaceutical Glass Packaging market include: Schott AG, Nipro Corporation, Owens-Illinois, Inc., Arab Pharmaceutical Glass Co., Sisecam Group,Stoelzle Oberglas GmbH, West Pharmaceutical Services, Inc., Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Shandong Medicinal Glass Co., Ltd., Ardagh Group S.A, Piramal Enterprises Ltd. and Gerresheimer AG.

Key Developments:

In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.

In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop new innovation and ideas about pharmaceutical packaging by focusing on augment reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.

In March 2023, Schott AG launched the production of FIOLAX®amber pharma glass in India with the aim to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

Products Covered:

• Vials
• Bottles
• Cartridges & Syringes
• Ampoules

Drug Types Covered:

• Generic
• Branded
• Biologic

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Packaging Market, By Product

• 5.1 Introduction
• 5.2 Vials
  • 5.2.1 Small vials
  • 5.2.2 Large vials
• 5.3 Bottles
  • 5.3.1 Small bottles
  • 5.3.2 Large bottles
• 5.4 Cartridges & Syringes
• 5.5 Ampoules

6 Global Pharmaceutical Glass Packaging Market, By Drug Type

• 6.1 Introduction
• 6.2 Generic
• 6.3 Branded
• 6.4 Biologic

7 Global Pharmaceutical Glass Packaging Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Schott AG
• 9.2 Nipro Corporation
• 9.3 Owens-Illinois, Inc.
• 9.4 Arab Pharmaceutical Glass Co.
• 9.5 Sisecam Group
• 9.6 Stoelzle Oberglas GmbH
• 9.7 West Pharmaceutical Services, Inc.
• 9.8 Beatson Clark
• 9.9 Bormioli Pharma S.p.A.
• 9.10 Corning Incorporated
• 9.11 Shandong Medicinal Glass Co., Ltd.
• 9.12 Ardagh Group S.A
• 9.13 Piramal Enterprises Ltd.
• 9.14 Gerresheimer AG